| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.3 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |